Morris Charles Q
Insider CIK 1489966 · ALTH Chief Medical Officer · RDUS Chief Medical Officer · PRLD Chief Medical Officer · LVTX Chief Medical Officer · IMGN Executive VP & CDO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRLD Prelude Therapeutics Inc | A Award deriv | 2026-05-01 | 2026-05-04 | 450,000 | $4.70 | $2.12M | 450,000 | SEC↗ |
| LVTX LAVA Therapeutics NV | A Award deriv | 2025-02-13 | 2025-02-18 | 130,850 | — | $0 | 130,850 | SEC↗ |
| RDUS Radius Health, Inc. | S Sale | 2020-02-26 | 2020-02-28 | 1,256 | $17.93 | $22.5K | 33,744 | SEC↗ |
| RDUS Radius Health, Inc. | A Award deriv | 2020-02-20 | 2020-02-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RDUS Radius Health, Inc. | A Award | 2020-02-20 | 2020-02-24 | 20,000 | — | $0 | 35,000 | SEC↗ |
| RDUS Radius Health, Inc. | A Award deriv | 2019-02-22 | 2019-02-26 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RDUS Radius Health, Inc. | A Award | 2019-02-22 | 2019-02-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RDUS Radius Health, Inc. | A Award deriv | 2018-09-04 | 2018-09-05 | 130,000 | — | $0 | 130,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2016-07-18 | 2016-07-20 | 110,000 | $3.05 | $335.5K | 110,000 | SEC↗ |
| IMGN IMMUNOGEN INC | S Sale | 2015-11-27 | 2015-11-30 | 5,170 | $14.00 | $72.4K | 27,090 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2015-07-13 | 2015-07-14 | 110,000 | $16.72 | $1.84M | 110,000 | SEC↗ |
| IMGN IMMUNOGEN INC | S Sale | 2014-11-28 | 2014-12-02 | 5,240 | $10.40 | $54.5K | 32,260 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2014-07-17 | 2014-07-18 | 110,000 | $10.79 | $1.19M | 110,000 | SEC↗ |
| IMGN IMMUNOGEN INC | M Exercise deriv | 2014-02-26 | 2014-02-27 | 6,936 | $11.93 | $82.7K | 172,254 | SEC↗ |
| IMGN IMMUNOGEN INC | M Exercise | 2014-02-26 | 2014-02-27 | 6,936 | $11.93 | $82.7K | 44,436 | SEC↗ |
| IMGN IMMUNOGEN INC | S Sale | 2014-02-26 | 2014-02-27 | 6,936 | $17.35 | $120.3K | 37,500 | SEC↗ |
| IMGN IMMUNOGEN INC | M Exercise deriv | 2014-02-20 | 2014-02-24 | 13,672 | $11.93 | $163.1K | 179,190 | SEC↗ |
| IMGN IMMUNOGEN INC | M Exercise | 2014-02-20 | 2014-02-24 | 13,672 | $11.93 | $163.1K | 51,172 | SEC↗ |
| IMGN IMMUNOGEN INC | S Sale | 2014-02-20 | 2014-02-24 | 13,672 | $17.10 | $233.8K | 37,500 | SEC↗ |
| IMGN IMMUNOGEN INC | M Exercise deriv | 2014-01-22 | 2014-01-23 | 1,603 | $11.93 | $19.1K | 192,862 | SEC↗ |
| IMGN IMMUNOGEN INC | S Sale | 2014-01-22 | 2014-01-23 | 1,603 | $17.00 | $27.3K | 37,500 | SEC↗ |
| IMGN IMMUNOGEN INC | M Exercise | 2014-01-22 | 2014-01-23 | 1,603 | $11.93 | $19.1K | 39,103 | SEC↗ |
| IMGN IMMUNOGEN INC | M Exercise deriv | 2014-01-21 | 2014-01-23 | 5,535 | $11.93 | $66.0K | 194,465 | SEC↗ |
| IMGN IMMUNOGEN INC | S Sale | 2014-01-21 | 2014-01-23 | 5,535 | $17.00 | $94.1K | 37,500 | SEC↗ |
| IMGN IMMUNOGEN INC | M Exercise | 2014-01-21 | 2014-01-23 | 5,535 | $11.93 | $66.0K | 43,035 | SEC↗ |
| IMGN IMMUNOGEN INC | S Sale | 2013-11-26 | 2013-11-27 | 12,500 | $13.75 | $171.9K | 37,500 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2013-07-16 | 2013-07-17 | 58,333 | $19.02 | $1.11M | 58,333 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | U Tender | 2012-09-04 | 2012-09-05 | 655,031 | $1.82 | $1.19M | 0 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | S Sale | 2012-04-27 | 2012-04-30 | 7,970 | $1.81 | $14.4K | 665,323 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | S Sale | 2012-04-27 | 2012-05-22 | 7,970 | $1.81 | $14.4K | 655,031 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | S Sale | 2012-03-01 | 2012-05-22 | 10,292 | $1.48 | $15.2K | 663,001 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | S Sale | 2012-02-29 | 2012-05-22 | 10,155 | $1.52 | $15.4K | 673,293 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | S Sale | 2012-02-29 | 2012-03-01 | 10,155 | $1.52 | $15.4K | 673,293 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | A Award | 2012-02-28 | 2012-05-22 | 241,848 | — | $0 | 683,448 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | A Award | 2012-02-28 | 2012-03-01 | 241,848 | — | $0 | 683,448 | SEC↗ |